Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.65 |
| ▸ | ALDH1A3 | P47895 | 3/20 | 0.65 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.65 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.64 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.39 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | STS | P08842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29258833 | 1.00 | ALDH1A1 (0.65) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL3181855 | 0.92 | ALDH1A1 (0.58) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL19313178 | 0.92 | ALDH1A1 (0.58) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL806381 | 0.92 | ALDH1A1 (0.58) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL3181867 | 0.92 | ALDH1A1 (0.58) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL13808643 | 0.92 | ALDH1A1 (0.58) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL181026 | 0.90 | ALDH1A1 (0.59) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL2199745 | 0.90 | ALDH1A1 (0.59) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL851178 | 0.90 | ALDH1A1 (0.59) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 | |
| SCHEMBL13649928 | 0.90 | ALDH1A1 (0.59) | ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 412 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117718078-B | Hydrophilic covalent organic framework catalyst for stably anchoring transition metal ions and preparation method and application thereof | CHINA UNIVERSITY OF PETROLEUM (EAST CHINA) (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122076269-A | Covalent organic framework mixed matrix membrane, in-situ growth method thereof and application thereof in ion separation | — | 2026-05-26 | — | — | CN | claimed |
| CN-122032347-A | Covalent organic framework-based heavy metal ion separation membrane and preparation method and application thereof | 中国科学院青岛生物能源与过程研究所 | 2026-05-15 | — | — | CN | claimed |
| US-12534498-B2 | Compounds for use as apelin receptor antagonists | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2026-01-27 | — | — | US | claimed |
| CN-115931823-B | In-situ preparation method of flexible SERS substrate based on nano film | 陕西师范大学 | 2025-05-30 | — | — | CN | claimed |
| CN-120054631-A | Selective hydrogenation catalyst and preparation method thereof | 中国石油天然气股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120058460-A | Hydrogenation method for carbon one-to-carbon three-fraction | 中国石油天然气股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119978364-A | Triphenylamine imidazole porous organic polymer, preparation method thereof and application thereof in proton conduction and photocatalysis antibiosis | 山东大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119954681-A | Small molecule photocrosslinker, preparation method and application | 南京工业大学 | 2025-05-09 | — | — | CN | claimed |
| CN-117463325-B | Alkyne selective hydrogenation catalyst and preparation method thereof | 中国石油天然气股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| EP-1957605-B1 | ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-01-11 | — | — | EP | claimed |
| US-9018409-B2 | Process for functionalization of unsaturated compounds | MEURICE R&D ASBL (BE) | 2015-04-28 | — | — | US | claimed |
| US-8591997-B2 | Process for preparing structured organic films (SOFS) via a pre-SOF | XEROX CORPORATION (US) | 2013-11-26 | — | — | US | claimed |
| EP-2632886-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | Meurice R&D ASBL (BE) | 2013-09-04 | — | — | EP | claimed |
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2013-08-15 | — | — | US | claimed |
| US-8304095-B2 | Organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2012-11-06 | — | — | US | claimed |
| WO-2012055946-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2012-05-03 | — | — | WO | claimed |
| US-20080272693-A1 | Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-11-06 | — | — | US | claimed |
| EP-1957605-A1 | ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2008-08-20 | — | — | EP | claimed |
| WO-2007065549-A1 | ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534498-B2 | Compounds for use as apelin receptor antagonists | APLNR, NPBWR1, AP3B1 | ALDH1A1 4464/4885ALDH1A3 4721/4885ALDH3A1 4503/4885 |
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | F10, RPP30, PUF60 | ALDH1A1 46/4885ALDH1A3 106/4885ALDH3A1 60/4885 |
| US-20080272693-A1 | Organic Electroluminescent Devices | EML4, MT-ND4L, EPCAM | ALDH1A1 600/4885ALDH1A3 237/4885ALDH3A1 1290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.